PAI-1 Antagonists: The Promise and the Peril

por Vaughan, Douglas E.
Publicado em 2011

Endothelial Function, Fibrinolysis, and Angiotensin‐Converting Enzyme Inhibition

por Vaughan, Douglas E.
Publicado no Clin Cardiol (1997)

Augmenting β receptors in the heart: Short-term gains offset by long-term pains?

por Limbird, Lee E., Vaughan, Douglas E.
Publicado em 1999

PAI-1 in Tissue Fibrosis

por Ghosh, Asish K., Vaughan, Douglas E.
Publicado em 2012

Endothelial biology in the post-menopausal obese woman

por Meadows, Judith L., Vaughan, Douglas E.
Publicado em 2011

Molecular and physiological manifestations and measurement of aging in humans

por Khan, Sadiya S., Singer, Benjamin D., Vaughan, Douglas E.
Publicado no Aging Cell (2017)

BIOLOGICAL PROPERTIES OF ENDOTHELIAL PROGENITOR CELLS (EPCS) AND THEIR POTENTIAL FOR CELL THERAPY

por Young, Pampee P., Vaughan, Douglas E., Hatzopoulos , Antonis K.
Publicado em 2007

Global Gene Expression Profiling in PAI-1 Knockout Murine Heart and Kidney: Molecular Basis of Cardiac-Selective Fibrosis

por Ghosh, Asish K., Murphy, Sheila B., Kishore, Raj, Vaughan, Douglas E.
Publicado em 2013

Inhibition of Plasminogen Activator Inhibitor 1 Attenuates Hepatic Steatosis but Does Not Prevent Progressive Nonalcoholic Steatohepatitis in Mice

por Henkel, Anne S., Khan, Sadiya S., Olivares, Shantel, Miyata, Toshio, Vaughan, Douglas E.
Publicado no Hepatol Commun (2018)

Role of Plasminogen Activator Inhibitor-1 in Senescence and Aging

por Eren, Mesut, Boe, Amanda E., Klyachko, Ekaterina A., Vaughan, Douglas E.
Publicado no Semin Thromb Hemost (2014)

Differential regulation of endothelial exocytosis of P-selectin and von Willebrand factor by protease-activated receptors and cAMP

por Cleator, John H., Zhu, Wen Qin, Vaughan, Douglas E., Hamm, Heidi E.
Publicado em 2006

PAI-1 is a Marker and a Mediator of Senescence

por Vaughan, Douglas E, Rai, Rahul, Khan, Sadiya S, Eren, Mesut, Ghosh, Asish K
Publicado no Arterioscler Thromb Vasc Biol (2017)

PAI-1 contributes to homocysteine-induced cellular senescence

por Sun, Tianjiao, Ghosh, Asish K., Eren, Mesut, Miyata, Toshio, Vaughan, Douglas E.
Publicado no Cell Signal (2019)

The Socrates Project for Difficult Diagnosis at Northwestern Medicine

por Singer, Benjamin D, Goodwin, Alexandra M, Patel, Anand A, Vaughan, Douglas E
Publicado no J Hosp Med (2020)

Structural Insight into the Two-Step Mechanism of PAI-1 Inhibition by Small Molecule TM5484

por Sillen, Machteld, Miyata, Toshio, Vaughan, Douglas E., Strelkov, Sergei V., Declerck, Paul J.
Publicado no Int J Mol Sci (2021)

Molecular basis of cardiac endothelial-to-mesenchymal transition (EndMT): Differential expression of microRNAs during EndMT

por Ghosh, Asish K., Nagpal, Varun, Covington, Joseph W., Michaels, Marissa A., Vaughan, Douglas E
Publicado em 2012

A Plasminogen Activator Inhibitor-1 Inhibitor Reduces Airway Remodeling in a Murine Model of Chronic Asthma

por Lee, Sun H., Eren, Mesut, Vaughan, Douglas E., Schleimer, Robert P., Cho, Seong H.
Publicado em 2012

PAI-1 is a critical regulator of FGF23 homeostasis

por Eren, Mesut, Place, Aaron T., Thomas, Paul M., Flevaris, Panagiotis, Miyata, Toshio, Vaughan, Douglas E.
Publicado no Sci Adv (2017)

Apelin Protects Against Angiotensin II-Induced Cardiovascular Fibrosis and Decreases PAI-1 Production

por Siddiquee, Khandaker, Hampton, Jessica, Khan, Susan, Zadory, Dan, Gleaves, Linda, Vaughan, Douglas E., Smith, Layton Harris
Publicado em 2011

Acetyltransferase p300 inhibitor reverses hypertension‐induced cardiac fibrosis

por Rai, Rahul, Sun, Tianjiao, Ramirez, Veronica, Lux, Elizabeth, Eren, Mesut, Vaughan, Douglas E., Ghosh, Asish K.
Publicado no J Cell Mol Med (2019)